Medical Pharmaceuticals The most-up-to-date pharmaceutical news stories, including medical, cosmetic, and supplemental treatments. This section contains releases covering all aspects of the pharmaceutical sector, from research, development, and testing, through to product launches and marketing. Topics include clinical trials and studies, as well as updates on the FDA approval process for new treatment options. Learn about upcoming events, conferences, and educational initiatives. Also included is financial and corporate information from the sector, such as board decisions, appointments and changes, industry awards, and quarterly reports.

Latest

24 Apr, 2017, 02:00 ET SIR-Spheres® Y-90 Resin Microspheres Substantially Improves Quality of Survival in Primary Liver Cancer, New Study Against Standard Treatment Shows

459-patient SARAH Study shows that local treatments of advanced or inoperable Hepatocellular Cancer (HCC) with SIR-Spheres Y-90 resin...


24 Apr, 2017, 01:00 ET Regeneron and Sanofi Receive Positive CHMP Opinion for Kevzara® (sarilumab) to Treat Adult Patients with Moderately to Severely Active Rheumatoid Arthritis

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the European Medicine Agency's (EMA) Committee for Medicinal...


24 Apr, 2017, 01:00 ET Shire Launches #PIPostsThanks Social Campaign to Raise Awareness of Primary Immunodeficiency (PI)

Shire plc (LSE: SHP, NASDAQ: SHPG), the global leader in rare diseases, is launching #PIPostsThanks, a social campaign to spotlight the unsung...


23 Apr, 2017, 22:54 ET Une nouvelle analyse d'une étude britannique démontre que la rifaximine-α réduit considérablement le nombre de visites aux urgences chez les patients atteints d'encéphalopathie hépatique

Norgine B.V. a présenté aujourd'hui une nouvelle analyse de l'étude britannique en situation réelle IMPRESS, qui démontre que le traitement de...


23 Apr, 2017, 22:52 ET Rifaximin-α: neue Analyse der Studie in Großbritannien zeigt eine signifikante Reduktion der Anzahl an Behandlungen von Patienten mit hepatitischer Enzephalopathie in der Notaufnahme

Norgine B.V. legte heute eine neue Analyse der in Großbritannien durchgeführten praxisbezogenen Studie IMPRESS vor, die belegt, dass eine...


23 Apr, 2017, 20:53 ET Kazi Hasan Media: Pioneers of Robotic Neuro-Rehab: Prywata, Hogan and Krebs

In the US there is a stroke victim every 4 seconds and a stroke related death every 4 minutes. Of the nearly 660,000 stroke survivors annually,...


23 Apr, 2017, 17:05 ET BD Announces Appointment Of Tom Polen As President

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today the appointment of Tom Polen, 43, as...


23 Apr, 2017, 17:04 ET BD To Acquire Bard For $24 Billion

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and C. R. Bard, Inc. (NYSE: BCR), a medical technology...


22 Apr, 2017, 14:30 ET Philips showcases newest MR-based innovations and the value of collaboration at ISMRM 2017

Royal Philips (NYSE: PHG; AEX: PHIA) today announced that it will feature the company's latest Magnetic Resonance (MR) solutions and...


22 Apr, 2017, 10:00 ET NGM Bio Announces NGM282 Dramatically Reduced Liver Fat and Other Biomarkers Associated With Nonalcoholic Steatohepatitis (NASH) in Phase 2 Trial

NGM Bio announced that its lead product candidate, NGM282, met the primary endpoint and key secondary endpoints in a Phase 2 trial of patients with...


22 Apr, 2017, 08:00 ET Shionogi Presents Results of the First Clinical Efficacy Trial and In Vitro Data on Cefiderocol (S-649266), a Siderophore Cephalosporin

Shionogi & Co., Ltd. today announced it will present for the first time clinical trial efficacy results, as well as supportive in vitro data,...


21 Apr, 2017, 18:45 ET Global Lab Automation Market to Reach $5.48 Billion by 2021: Analysis By Equipment and Software, Application, Type, End User & Region - Research-and-Markets

Research and Markets has announced the addition of the "Lab Automation Market by Equipment & Software, Applications, Type, & End Users -...


21 Apr, 2017, 18:31 ET Dr. Eric Lawitz, of the Texas Liver Institute, Presents Groundbreaking Research in Nonalcoholic Steatohepatitis (NASH) at the International Liver Congress™ 2017

Dr. Eric Lawitz, internationally recognized for his work in liver disease, presented a proof-of-concept study at The International Liver Congress™...


21 Apr, 2017, 18:30 ET Global X-Ray Equipment Market Analysis 2016-2021: Market is Expected to be Driven by Mobile x-ray Equipment - Research and Markets

Research and Markets has announced the addition of the "Global X-Ray Equipment Market (CT, Mammography, C-Arms, Dental, Mobile X-Ray): Analysis By...


21 Apr, 2017, 17:19 ET Jeffrey M. Nuskind, M.S., DABR is recognized by Continental Who's Who

Jeffrey M. Nuskind, M.S., DABR is recognized by Continental Who's Who as a Pinnacle Lifetime Member in the Medical field. Nuskind's professional...


21 Apr, 2017, 16:30 ET Research and Markets - Global $2.47 Billion Acquired Hemophilia Treatment Market, 2023: Key Players are Baxalta, Novo Nordisk, Biogen, Pfizer & F. Hoffman La Roche

Research and Markets has announced the addition of the "Global Acquired Hemophilia Treatment Market Size, Market Share, Application Analysis,...


21 Apr, 2017, 16:13 ET PCMA: New Analysis Finds C-THRU Act Would Increase Federal Spending by $20 Billion

A new Moran Company study examining the budgetary impact of S. 637, "Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act," introduced...


21 Apr, 2017, 16:01 ET Penumbra, Inc. Appoints Bridget O'Rourke to its Board of Directors

Penumbra, Inc. (NYSE: PEN) today announced that Bridget O'Rourke has been appointed to its Board of Directors, effective immediately. Ms....


21 Apr, 2017, 16:01 ET Arena Pharmaceuticals Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares

Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) today announced the completion of its previously announced underwritten public offering of 69,000,000...


21 Apr, 2017, 16:00 ET Everolimus Sales, Price Analysis, & Sales Forecasts 2016-2021 - Research and Markets

Research and Markets has announced the addition of the "Everolimus Sales, Price Analysis, & Sales Forecast - 2017" report to their offering....


21 Apr, 2017, 16:00 ET Amgen Announces Webcast Of 2017 First Quarter Financial Results

Amgen (NASDAQ:AMGN) today announced that it will report its first quarter financial results on Wednesday, April 26, 2017, after the close of the...


21 Apr, 2017, 15:45 ET Doxorubicin Sales, Price Analysis, & Sales Forecasts 2016-2021 - Research and Markets

Research and Markets has announced the addition of the "Doxorubicin Sales, Price Analysis, & Sales Forecast - 2017" report to their offering....


21 Apr, 2017, 15:30 ET Guaifenesin Sales, Price Analysis, & Sales Forecast 2017-2021 - Research and Markets

Research and Markets has announced the addition of the "Guaifenesin Sales, Price Analysis, & Sales Forecast - 2017" report to their offering....


21 Apr, 2017, 15:04 ET 20 Year Old Kibow Biotech Further Validates Enteric Dialysis® Concept, With Greater Understanding of Modulating the Gut Microbiome with Pro/Prebiotics Towards Maintaining Healthy Kidney Function

One of the world's prominent meetings in nephrology, the ISN World Congress of Nephrology is being held in Mexico City, Mexico from April 21st-25th...


21 Apr, 2017, 15:00 ET CSSi LifeSciences™ Executives Featured at Colorado BioScience Association BioBoot Camp 2017

Today, Friday, April 21, 2017, members of CSSi LifeSciences™'s executive team served as featured speakers for BioBoot Camp 2017, a signature...